Patent · US Active

Heterocyclic antiviral compounds

US8273773B2 · kind B2 · utility

10Cited by
0References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 2009
Grant dateSep 25, 2012
Priority date—
Expiry dateOct 30, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds having the formula I wherein R1, R2, R3, R4a, R4b, R4c, R5, R6, R9 and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.